George Farmer, Ph.D., Appointed Chief Financial Officer at PureTech: Experienced Financial Analyst & Biotech Executive Complements the Team

January 5, 2021

George Farmer, Ph.D. is the new chief financial officer at PureTech. Dr. Farmer will be responsible for all aspects of the Company’s finances, including capital markets strategy and execution, strategic and financial planning, and financial reporting.

“We are delighted to welcome George to the senior leadership team as we are poised to build on the momentum of the past year,” said Daphne Zohar, Founder and Chief Executive Officer of PureTech. “This is an important moment for PureTech, as we recently initiated three clinical trials based on programs from our Wholly Owned Pipeline and expanded our presence with the NASDAQ Global Market listing. We believe that George’s depth of experience will be very helpful as we share the PureTech story with a broader community of investors.”

Dr. George Farmer joins PureTech from BMO Capital Markets where he completed a 15-year career as a senior biotechnology equity analyst providing in-depth sector research for institutional investor clients. Prior to this role, Dr. Farmer served as Chief Executive Officer of Cortice Biosciences, a privately held biotechnology company focused on the clinical development of therapies for brain malignancies and neurodegenerative diseases. He also served as Vice President of Corporate Development at Synta Pharmaceuticals, a publicly traded company developing cancer therapeutics. Dr. Farmer was a postdoctoral fellow at Sloan Kettering Cancer Center and University of California San Francisco after receiving his Ph.D. in Biological Sciences from Columbia University and a B.A. from Dartmouth College.

“PureTech has built a leadership position in the science of the brain-immune-gut axis, which has led to the discovery and development of novel medicines.  I am particularly intrigued by the potential of LYT-100 for treating multiple fibrotic diseases and LYT-200 as a potential new cancer immunotherapeutic.  Just as impressive is the track record of management, which has developed a deep therapeutic pipeline both internally and through the Company’s Founded Entities,” Dr. George Farmer said. “I am very excited to become a member of the PureTech team.”

 

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."